While vepdegestrant outperformed a standard treatment option in a subtype of patients, the benefit on progression-free ...

As newborn screening and rapid DNA sequencing become routine, we are poised to catch and treat inherited diseases at their ...

Neuroscientists can now make precise genetic tweaks to the neurons that are most affected by brain diseases such as Parkinson ...

For investors still seeking companiies with attractive long-term prospects, let's consider two in the biotech industry: ...

This first-in-human trial is testing a highly unconventional method: delivering fat-derived stem cells from the patient ...

Panelists discuss how the future of polycythemia vera (PV) management will be shaped by advancements in targeted therapies, ...

Greater numbers of circulating stem cells increase the efficacy of in vivo gene therapy techniques, potentially reducing the price tag of lifesaving treatments.

The Retina World Congress showcases global innovations in surgical and medical retina, highlighting emerging treatments and ...

A 14-gene molecular assay could help predict which patients with early-stage non-small cell lung cancer will benefit from ...

A molecular test identified patients with high-risk early lung cancer who significantly benefitted from adjuvant chemotherapy ...

Intellia’s stock fell 23% after one patient in its Phase III MAGNITUDE trial developed severe liver toxicity that later ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...